New bone formation induced by surface strontium-modified ceramic bone graft substitute.

Bone graft substitutes are widely used in regenerative surgery to support new bone growth. While osteoconductive materials provide a scaffold for bone formation, they lack the ability to actively promote osteogenesis. Strontium ions have been shown to influence bone healing in various contexts, but their role in surface-modified bone grafts remains underexplored. Prior research has demonstrated that strontium can enhance osteoblast activity and mineralization, yet the specific effects of localized surface Sr delivery on bone substitute performance are unclear. This gap motivated the current investigation into how Sr surface modification might improve the osteogenic potential of ceramic bone grafts. The study aimed to determine whether Sr could be effectively delivered to the surface of bone substitutes and whether this modification would enhance early bone healing. The need for improved regenerative materials in periodontal and maxillofacial surgery remains high, particularly in cases requiring rapid healing. This work addresses a specific need to evaluate the osteogenic impact of Sr-modified ceramic grafts in both in vitro and in vivo settings.

The study aimed to evaluate how surface strontium modification affects the osteogenic activity of a ceramic bone graft substitute. The goal was to determine whether Sr could be effectively delivered to the surface of the graft and whether this modification would enhance early bone healing. The researchers focused on comparing the performance of Sr-modified grafts with unmodified ceramic grafts and other clinically available bone substitutes. The motivation stemmed from the known beneficial effects of Sr on bone healing in other contexts, such as osteoporosis treatment. The study also sought to assess whether Sr modification could be achieved using a simple wet chemical treatment. The researchers wanted to understand if this modification could promote osteogenic differentiation of stem cells and improve bone regeneration in animal models. The study's specific problem was the limited osteogenic activity of standard osteoconductive bone grafts, which often require additional growth factors or cells to achieve optimal results. By addressing this limitation, the study aimed to contribute to the development of more effective bone graft materials.

The researchers used a wet chemical treatment to modify the surface of particulate porcine bone graft material with strontium ions. This method allowed for the controlled delivery of Sr to the surface of the graft. The modified grafts were then analyzed for structural changes using imaging techniques to identify the formation of Sr-containing microstructures and nanostructures. Sr release from the modified grafts was monitored to assess its sustained delivery properties. In vitro experiments involved exposing bipotential ST2 stem cells to the modified grafts to evaluate their osteogenic differentiation potential. The study also included in vivo testing in a rabbit calvarial defect model to assess the effect of Sr modification on new bone formation during the early healing period. The researchers compared the results of the Sr-modified grafts with those of unmodified ceramic bone grafts and other clinically available bone substitutes. The experimental design ensured that both structural and biological outcomes were evaluated to determine the overall effectiveness of the Sr modification.

The Sr-modified bone substitute formed a Sr-containing microstructured surface layer and additional nanostructures. The modification resulted in sustained Sr release from the graft material. In vitro, the Sr-modified grafts promoted osteogenic differentiation of ST2 stem cells compared to unmodified controls. In vivo, the modified grafts increased the amount of newly formed bone in rabbit calvarial defects during the early healing period. The Sr-modified grafts outperformed unmodified ceramic bone grafts in terms of early bone formation. The Sr-modified grafts also showed comparable or better performance than other clinically available synthetic or allograft bone substitutes. The sustained Sr release from the modified surface likely contributed to the observed enhancement in osteogenic activity. These findings suggest that Sr surface modification can improve the early healing capacity of osteoconductive bone grafts.

The Sr-modified bone substitute demonstrated enhanced osteogenic activity compared to unmodified grafts and other available bone substitutes. The formation of Sr-containing microstructures and nanostructures on the surface likely contributed to the observed effects. The sustained Sr release from the modified grafts supported prolonged osteogenic stimulation. The in vitro results showed that Sr modification promoted stem cell differentiation into osteoblasts. In vivo, the modified grafts increased new bone formation in early healing periods. These findings suggest that Sr surface modification is a promising strategy to improve the performance of osteoconductive bone grafts. The study supports the potential use of Sr-modified grafts in periodontal and maxillofacial regenerative surgery. The results align with the authors' hypothesis that Sr modification could enhance the early healing capacity of bone graft substitutes.